0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letter to the Editor   |    
Clonidine Treatment for Hallucinogen Persisting Perception Disorder
ARTURO G. LERNER, M.D.; BORIS FINKEL, M.D.; IGOR OYFFE, M.D., PH.D.; INNA MERENZON, M.D.; MIRCEA SIGAL, M.D.
Am J Psychiatry 1998;155:1460-1460.
View Author and Article Information

Letters to the Editor

To the Editor: We have successfully treated with clonidine three patients who met DSM-IV criteria for hallucinogen persisting perception disorder. We report the most representative case.

Mr. A was a 25-year-old man with a previous history of benzodiazepine, "ecstasy," LSD, and cannabis abuse. There was no other significant medical or psychiatric history. Mr. A reported being bothered by flashbacks of flashes of colors, trails of images of moving objects, body image distortion, and spontaneous imagery. These episodes usually lasted between a fraction of a second and a few minutes. They were severe enough to cause clinically significant distress, anxiety, and impairment in social and occupational functioning. After obtaining written consent, we started Mr. A on a regimen of 0.025 mg of clonidine three times a day. After 1 month of treatment, he reported considerable improvement in both the number of flashbacks and the accompanying anxiety. Over next 2 months, symptoms disappeared completely; we then discontinued the clonidine. Mr. A remained symptom free over a 6-month follow-up period.

Benzodiazepines appear to be useful for some patients who suffer from hallucinogen persisting perception disorder R3915510CEBDAEEJ, but its abuse potential might be troublesome for those with substance-related disorders.

It was hypothesized that the hyperarousal, traumatic nightmares, and flashbacks that characterize posttraumatic stress syndrome (PTSD) are related to long-term potentiation of locus ceruleus pathways to the hippocampus and amygdala R3915510CEBDFIGF. Pharmacological agents that can dampen the hyperarousal associated with PTSD should have a palliative if not a curative role R3915510CEBCFHGI. Clonidine suppresses locus ceruleus activity and reduces adrenergic activity R3915510CEBBGCEI; thus, it appears to be helpful in the treatment of PTSD R3915510CEBCBDFB. We think that LSD-related flashbacks, like PTSD-related flashbacks, may be associated with excessive sympathetic nervous activity; therefore, clonidine may alleviate this condition.

In our experience, clonidine at low doses is well tolerated, has minimal side effects, and has no potential for abuse.

We suggest that clonidine should be considered as an option for certain patients who suffer from LSD-related flashbacks.

Abraham HD: Visual phenomenology of the LSD flashbacks. Arch Gen Psychiatry  1983; 40:884–889
[PubMed]
 
van der Kolk B, Greenberg M, Boyd H, Krystal J: Inescapable shock, neurotransmitters, and addiction to trauma: toward a psychobiology of posttraumatic stress. Biol Psychiatry  1985; 20:314–325
[PubMed]
[CrossRef]
 
Friedman MJ: Toward rational pharmacotherapy for posttraumatic stress disorder: an interim report. Am J Psychiatry  1988; 145:281–285
[PubMed]
 
Davidson J: Drug therapy for post-traumatic stress disorder. Br J Psychiatry  1992; 160:309–314
[PubMed]
[CrossRef]
 
Kolb L, Burris BC, Griffiths S: Propranolol and clonidine in the treatment of post traumatic disorders of war, in Post Traumatic Stress Disorder: Psychological and Biological Sequelae. Edited by van der Kolk BA. Washington, DC, American Psychiatric Press, 1984, pp 97–107
 
+

References

Abraham HD: Visual phenomenology of the LSD flashbacks. Arch Gen Psychiatry  1983; 40:884–889
[PubMed]
 
van der Kolk B, Greenberg M, Boyd H, Krystal J: Inescapable shock, neurotransmitters, and addiction to trauma: toward a psychobiology of posttraumatic stress. Biol Psychiatry  1985; 20:314–325
[PubMed]
[CrossRef]
 
Friedman MJ: Toward rational pharmacotherapy for posttraumatic stress disorder: an interim report. Am J Psychiatry  1988; 145:281–285
[PubMed]
 
Davidson J: Drug therapy for post-traumatic stress disorder. Br J Psychiatry  1992; 160:309–314
[PubMed]
[CrossRef]
 
Kolb L, Burris BC, Griffiths S: Propranolol and clonidine in the treatment of post traumatic disorders of war, in Post Traumatic Stress Disorder: Psychological and Biological Sequelae. Edited by van der Kolk BA. Washington, DC, American Psychiatric Press, 1984, pp 97–107
 
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 15.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 15.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 15.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 15.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 6.  >
Topic Collections
Psychiatric News
PubMed Articles